Relationship between P-wave duration and the risk of atrial fibrillation

References

• Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA. 2001;285:2370–2375.
   PubMed Web of Science ®Google Scholar
• Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in olmsted county, minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–125.
   PubMed Web of Science ®Google Scholar
• Kamel H, Okin PM, Longstreth WT, et al. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol. 2015;11:323–331.
   PubMed Web of Science ®Google Scholar
• Huo Y, Mitrofanova L, Orshanskaya V, et al. P-wave characteristics and histological atrial abnormality. J Electrocardiol. 2014;47:275–280.
   PubMed Web of Science ®Google Scholar
• Magnani JW, Zhu L, Lopez F, et al. P-wave indices and atrial fibrillation: cross-cohort assessments from the framingham heart study and atherosclerosis risk in communities study. Am Heart J. 2015;169:53–61.
   PubMed Web of Science ®Google Scholar
• Nielsen JB, Kühl JT, Pietersen A, et al. P-wave duration and the risk of atrial fibrillation: results from the copenhagen ECG study. Heart Rhythm. 2017;12:1887–1895.
   Web of Science ®Google Scholar
• Soliman EZ, Prineas RJ, Case LD, et al. Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2009;40:1204–1211.
   PubMed Web of Science ®Google Scholar
• Henein M Left Atrial Function in Health and Disease.; 2012
   Google Scholar
• Corradi D, Maestri R, Macchi E, et al. Clinical reviews: the Atria: from morphology to function. J Cardiovasc Electrophysiol. 2010;22:223–235.
   PubMedGoogle Scholar
• Anderson RH, Cook AC. The structure and components of the atrial chambers. Europace. 2007;9:vi3–9.
   PubMed Web of Science ®Google Scholar
• Hellerstein HK, Orbison JL. Anatomic variations of the orifice of the human coronary sinus. Circulation. 1951;3:514–523.
   PubMed Web of Science ®Google Scholar
• De PR, Ho SY, Salerno-Uriarte JA, et al. Electroanatomic analysis of sinus impulse propagation in normal human atria. J Cardiovasc Electrophysiol. 2002;13:1–10.
   PubMedGoogle Scholar
• Soliman EZ, Alonso A, Misialek J, et al. Reference ranges of PR duration and P-wave indices in individuals free of cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). J Electrocardiol. 2013;46:702–706.
   PubMed Web of Science ®Google Scholar
• Kottkamp H. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. Eur Heart J. 2013;34:2731–2738.
   PubMed Web of Science ®Google Scholar
• Boldt A, Wetzel U, Lauschke J, et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart. 2004;90:400–405.
   PubMed Web of Science ®Google Scholar
• Thanassoulis G, Massaro JM, O’Donnell CJ, et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham heart study. Circ Arrhythmia Electrophysiol. 2010;3:345–350.
   PubMed Web of Science ®Google Scholar
• Platonov PG, Mitrofanova LB, Orshanskaya V, et al. Structural abnormalities in atrial walls are associated with presence and persistence of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58:2225–2232.
   PubMed Web of Science ®Google Scholar
• Turgut O, Tandogan I, Yilmaz MB, et al. Association of P wave duration and dispersion with the risk for atrial fibrillation: practical considerations in the setting of coronary artery disease. Int J Cardiol. 2010;144:322–324.
   PubMed Web of Science ®Google Scholar
• Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51:802–809.
   PubMed Web of Science ®Google Scholar
• Darbar D, Hardy A, Haines JL, et al. Prolonged signal-averaged P-Wave duration as an intermediate phenotype for familial atrial fibrillation. J Am Coll Cardiol. 2008;51:1083–1089.
   PubMed Web of Science ®Google Scholar
• Centurion OA, Isomoto S, Fukatani M, et al. Relationship between atrial conduction defects and fractionated atrial endocardial electrograms in patients with sick sinus syndrome. Pacing Clin Electrophysiol. 1993;16:2022–2033.
   PubMed Web of Science ®Google Scholar
• Francia P, Ricotta A, Balla C, et al. P-wave duration in lead aVR and the risk of atrial fibrillation in hypertension. Ann Noninvasive Electrocardiol. 2015;20:167–174.
   PubMed Web of Science ®Google Scholar
• Conte G, Luca A, Yazdani S, et al. Usefulness of P-wave duration and morphologic variability to identify patients prone to paroxysmal atrial fibrillation. Am J Cardiol. 2017;119:275–279.
   PubMed Web of Science ®Google Scholar
• Wang YS, Chen GY, Li XH, et al. Prolonged P-wave duration is associated with atrial fibrillation recurrence after radiofrequency catheter ablation: A systematic review and meta-analysis. Int J Cardiol. 2017;227:355–359.
   PubMed Web of Science ®Google Scholar
• Yiǧit Z, Akdur H, Ersanli M, et al. The effect of exercise to P wave dispersion and its evaluation as a predictor of atrial fibrillation. Ann Noninvasive Electrocardiol. 2003;8:308–312.
   PubMed Web of Science ®Google Scholar
• Andrikopoulos GK, Dilaveris PE, Richter DJ, et al. Increased variance of P wave duration on the electrocardiogram distinguishes patients with idiopathic paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000;23:1127–1132.
   PubMed Web of Science ®Google Scholar
• De Bacquer D, Willekens J, De Backer G. Long-term prognostic value of P-wave characteristics for the development of atrial fibrillation in subjects aged 55 to 74 years at baseline. Am J Cardiol. 2007;100:850–854.
   PubMed Web of Science ®Google Scholar
• Smith JW, O ’Neal WT, Shoemaker MB, et al. PR-interval components and atrial fibrillation risk (From the atherosclerosis risk in communities study). Am J Cardiol. 2017;119:466–472.
   PubMed Web of Science ®Google Scholar
• Frisella ME, Robinette MM, Spodick DH. Interatrial block: pandemic prevalence concealed by anachronistic electrocardiographic standards. Clin Cardiol. 2005;28:381–383.
   PubMed Web of Science ®Google Scholar
• Stafford PJ, Turner I, Vincent R. Quantitative analysis of signal-averaged P waves in idiopathic paroxysmal atrial fibrillation. Am J Cardiol. 1991;68:751–755.
   PubMed Web of Science ®Google Scholar
• Stafford PJ, Kolvekar S, Cooper J, et al. Signal averaged P wave compared with standard electrocardiography or echocardiography for prediction of atrial fibrillation after coronary bypass grafting. Heart. 1997;77:417–422.
   PubMed Web of Science ®Google Scholar
• Guidera SA, Steinberg JS. The signal-averaged P wave duration: A rapid and noninvasive marker of risk of atrial fibrillation. J Am Coll Cardiol. 1993;21:1645–1651.
   PubMed Web of Science ®Google Scholar
• Fukunami M, Yamada T, Ohmori M, et al. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation. 1991;83:162–169.
   PubMed Web of Science ®Google Scholar
• Steinberg JS, Zelenkofske S, Wong SC, et al. Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation. 1993;88:2618–2622.
   PubMed Web of Science ®Google Scholar
• Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009;373:739–745.
   PubMed Web of Science ®Google Scholar
• Schnabel RB, Aspelund T, Li G, et al. Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med. 2010;170:1909–1917.
   PubMedGoogle Scholar
• Rangel MO, O’Neal WT, Soliman EZ. Usefulness of the electrocardiographic P-wave axis as a predictor of atrial fibrillation. Am J Cardiol. 2016;117:100–104.
   PubMed Web of Science ®Google Scholar
• Alonso A, Krijthe BP, Aspelund T, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2:e000102.
   PubMed Web of Science ®Google Scholar
• Chamberlain AM, Agarwal SK, Folsom AR, et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol. 2011;107:85e91.
   Web of Science ®Google Scholar
• Aro AL, Anttonen O, Kerola T, et al. Prognostic significance of prolonged PR interval in the general population. Eur Heart J. 2014;35:123–129.
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Cammarata M, Li Y. Explaining the inconsistent associations of PR interval with mortality: the role of P-duration contribution to the length of PR interval. Heart Rhythm. 2014;11:93–98.
   PubMed Web of Science ®Google Scholar
• Tereshchenko LG, Shah AJ, Li Y, et al. Electrocardiographic deep terminal negativity of the P wave in V1 and risk of mortality: the national health and nutrition examination survey III. J Cardiovasc Electrophysiol. 2014;25:1242–1248.
   PubMed Web of Science ®Google Scholar
• Tereshchenko LG, Henrikson CA, Sotoodehnia N, et al. Electrocardiographic deep terminal negativity of the P wave in V(1) and risk of sudden cardiac death: the Atherosclerosis Risk in Communities (ARIC) study. J Am Heart Assoc. 2014;3:e001387.
   PubMed Web of Science ®Google Scholar
• Kamel H, Bartz TM, Longstreth WT, et al. Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study. Stroke. 2015;46:711–716.
   PubMed Web of Science ®Google Scholar
• Liu G, Tamura A, Torigoe K, et al. Abnormal P-wave terminal force in lead V1 is associated with cardiac death or hospitalization for heart failure in prior myocardial infarction. Heart Vessels. 2013;28:690–695.
   PubMed Web of Science ®Google Scholar
• German DM, Kabir MM, Dewland TA, et al. Atrial fibrillation predictors: importance of the electrocardiogram. Ann Noninvasive Electrocardiol. 2016;21:20–29.
   PubMed Web of Science ®Google Scholar
• Jin L, Weisse AB, Hernandez F, et al. Significance of electrocardiographic isolated abnormal terminal P-wave force (left atrial abnormality). An echocardiographic and clinical correlation. Arch Intern Med. 1988;148:1545–1549.
   PubMedGoogle Scholar
• Tanoue MT, Kjeldsen SE, Devereux RB, et al. Relationship between abnormal P-wave terminal force in lead V1 and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study. Blood Press. 2017;26:94–101.
   PubMed Web of Science ®Google Scholar
• Centurión OA, Isomoto S, Shimizu A, et al. The effects of aging on atrial endocardial electrograms in patients with paroxysmal atrial fibrillation. Clin Cardiol. 2003;26:435–438.
   PubMed Web of Science ®Google Scholar
• Knuiman M, Briffa T, Divitini M, et al. A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study. Eur J Epidemiol. 2014;29:181–190.
   PubMed Web of Science ®Google Scholar
• Kamel H, Hunter M, Moon YP, et al. Electrocardiographic left atrial abnormality and risk of stroke: northern manhattan study. Stroke. 2015;46:3208–3212.
   PubMed Web of Science ®Google Scholar
• Kamel H, Soliman EZ, Heckbert SR, et al. P-wave morphology and the risk of incident ischemic stroke in the multi-ethnic study of atherosclerosis. Stroke. 2014;45:2786–2788.
   PubMed Web of Science ®Google Scholar
• Kamel H, Bartz TM, Elkind MSV, et al. Atrial cardiopathy and the risk of ischemic stroke in the CHS (Cardiovascular Health Study). Stroke. 2018;49:980–986.
   PubMed Web of Science ®Google Scholar
• Kamel H, O’Neal WT, Okin PM, et al. Electrocardiographic left atrial abnormality and stroke subtype in the atherosclerosis risk in communities study. Ann Neurol. 2015;78:670–678.
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Norby FL, Soliman EZ, et al. Abnormal P-Wave Axis and Ischemic Stroke: the ARIC Study (Atherosclerosis Risk In Communities). Stroke. 2017;48:2060–2065.
   PubMed Web of Science ®Google Scholar
• AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke (ARCADIA). ClinicalTrials.gov Identifier: NCT03192215. Available from: https://clinicaltrials.gov/ct2/show/NCT03192215
   Google Scholar